Durect Stock (NASDAQ:DRRX), Quotes and News Summary

Q: What sector and industry does Durect (DRRX) operate in?

Durect is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Durect Stock (NASDAQ: DRRX) stock price, news, charts, stock research, profile.

Open	$0.880
Close	$0.910
Volume / Avg.	115.709K / 188.702K
Day Range	0.857 - 0.940
52 Wk Range	0.470 - 7.460
Market Cap	$27.625M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	3.35%
Days to Cover	7.57

Recent News

Top 3 Health Care Stocks That Are Preparing To Pump This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Avi Kapoor

Crude Oil Falls 2.5%; Ralph Lauren Posts Upbeat Earnings

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling around 80 points on Wednesday The Dow traded down 0.23% to 34,074.30 while the NASDAQ fell 0.01% to 13,638.07. The S&P 500 also fell, dropping, 0.01% to 4,378.16.

Lisa Levin

Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Durect Corp

Sector

Health Care

Industry

Pharmaceuticals

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufact...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Durect (DRRX) stock?

You can purchase shares of Durect (NASDAQ: DRRX) through any online brokerage.

View our list of the best stock brokerages.

Who are Durect's (DRRX) competitors?

Other companies in Durect’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Jaguar Health (NASDAQ:JAGX).

What is the target price for Durect (DRRX) stock?

The latest price target for Durect (NASDAQ: DRRX) was reported by Oppenheimer on Monday, April 1, 2024. The analyst firm set a price target for 5.00 expecting DRRX to rise to within 12 months (a possible 461.73% upside). 8 analyst firms have reported ratings in the last year.

Current Stock Price for Durect (DRRX)?

The stock price for Durect (NASDAQ: DRRX) is $0.8901 last updated April 17, 2024 at 6:10 PM EDT.

Does Durect (DRRX) pay a dividend?

There are no upcoming dividends for Durect.

When is Durect (NASDAQ:DRRX) reporting earnings?

Durect’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is Durect (DRRX) going to split?

There is no upcoming split for Durect.

What sector and industry does Durect (DRRX) operate in?

Durect is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-